FUTURA MEDICAL PLC Logo

FUTURA MEDICAL PLC

Pharmaceutical company developing topical gel formulations for sexual health.

FUM | IL

Overview

Corporate Details

ISIN(s):
GB0033278473
LEI:
21380053QLT46UNV2303
Country:
United Kingdom
Address:
Surrey Technology Centre, GU2 7YG Guildford

Description

Futura Medical is a pharmaceutical company specializing in the research, development, and global commercialization of innovative sexual health products. The company's core strength is its expertise in proprietary, topically delivered gel formulations. Its lead product, Eroxon®, is a clinically proven, fast-acting topical gel for the treatment of erectile dysfunction (ED). Eroxon® is distinguished by its rapid onset of action, helping users achieve an erection within 10 minutes, and is available over-the-counter in major markets including the USA and Europe. The company utilizes a de-risked commercialization strategy, establishing partnerships with leading consumer healthcare companies for distribution and marketing. Futura Medical's development pipeline also includes potential treatments for female sexual dysfunction.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-23 17:50
Notification of major holdings
English 51.2 KB
2025-12-18 19:25
Notification of major holdings
English 21.4 KB
2025-12-18 18:55
Notification of major holdings
English 50.4 KB
2025-12-12 17:30
Notification of major holdings
English 22.3 KB
2025-12-10 13:15
Notification of major holdings
English 21.0 KB
2025-12-10 13:10
Notification of major holdings
English 21.0 KB
2025-12-10 08:35
Patent notice of allowance granted for China
English 13.8 KB
2025-12-09 17:10
Block Listing Six Monthly Return
English 20.3 KB
2025-12-08 14:45
Notification of major holdings
English 22.4 KB
2025-12-08 13:30
Directors' / PDMR dealing
English 49.0 KB
2025-12-04 16:55
Notification of major holdings
English 51.2 KB
2025-12-04 16:55
Notification of major holdings
English 20.9 KB
2025-12-03 08:20
Board change
English 14.4 KB
2025-12-02 12:40
Result of General Meeting and Total Voting Rights
English 23.1 KB
2025-11-14 17:50
PCA Dealing
English 23.2 KB

Automate Your Workflow. Get a real-time feed of all FUTURA MEDICAL PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for FUTURA MEDICAL PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for FUTURA MEDICAL PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.